{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:40:30Z","timestamp":1768250430370,"version":"3.49.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1093\/humrep\/dex220","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T19:15:49Z","timestamp":1495739749000},"page":"1639-1647","source":"Crossref","is-referenced-by-count":21,"title":["A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials"],"prefix":"10.1093","volume":"32","author":[{"given":"Khalid","family":"Abd-Elaziz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Duijkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"St\u00f6ckl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Klipping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelvin","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Goletz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"key":"key\n\t\t\t\t20170720082429_dex220C1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1439-0272.2002.00493.x","article-title":"Distribution and function of FSH receptor genetic variants in normal men","volume":"34","year":"2002","journal-title":"Andrologia"},{"key":"key\n\t\t\t\t20170720082429_dex220C2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0304-4157(88)90012-3","article-title":"Pituitary glycoprotein hormone oligosaccharides: structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin","volume":"947","year":"1988","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20170720082429_dex220C3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1477-7827-1-63","article-title":"Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization","volume":"1","year":"2003","journal-title":"Reprod Biol Endocrinol"},{"key":"key\n\t\t\t\t20170720082429_dex220C4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1023656225053","article-title":"Inhibin B predicts oocyte number and the ratio IGF-I\/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization","volume":"20","year":"2003","journal-title":"J Assist Reprod Genet"},{"key":"key\n\t\t\t\t20170720082429_dex220C5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/glycob\/cwg020","article-title":"Glycosylation of human recombinant gonadotrophins: characterization and batch-to-batch consistency","volume":"13","year":"2003","journal-title":"Glycobiology"},{"key":"key\n\t\t\t\t20170720082429_dex220C6","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/oxfordjournals.humrep.a138440","article-title":"Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine: characterization of non-gonadotrophin proteins","volume":"9","year":"1994","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170720082429_dex220C7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/humupd\/4.6.862","article-title":"Recombinant follicle stimulating hormone: development of the first biotechnology product for the treatment of infertility. Recombinant Human FSH Product Development Group","volume":"4","year":"1998","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170720082429_dex220C8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jcem-70-2-328","article-title":"Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists","volume":"70","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20170720082429_dex220C9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1530\/eje.1.01871","article-title":"Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women","volume":"152","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20170720082429_dex220C10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2125.1998.00644.x","article-title":"The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women","volume":"45","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170720082429_dex220C11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09513590500402756","article-title":"Evidence for cycle-dependent expression of follicle-stimulating hormone receptor in human endometrium","volume":"21","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20170720082429_dex220C12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0015-0282(16)56644-8","article-title":"Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH","volume":"61","year":"1994","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170720082429_dex220C13","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/jcph.328","article-title":"Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line","volume":"54","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170720082429_dex220C14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s40261-015-0276-8","article-title":"Dose-exposure proportionality of a novel recombinant follicle-stimulating hormone (rFSH), FE 999049, derived from a human cell line, with comparison between Caucasian and Japanese women after subcutaneous administration","volume":"35","year":"2015","journal-title":"Clin Drug Investig"},{"key":"key\n\t\t\t\t20170720082429_dex220C15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0090-9556(25)07318-0","article-title":"Pharmacokinetics of recombinant human follicle stimulating hormone after intravenous, intramuscular, and subcutaneous administration in monkeys, and comparison with intravenous administration of urinary follicle stimulating hormone","volume":"21","year":"1993","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t20170720082429_dex220C16","first-page":"259","article-title":"Biomarkers of ovarian reserve","volume":"3","year":"2008","journal-title":"Biomark Insights"},{"key":"key\n\t\t\t\t20170720082429_dex220C17","first-page":"739","article-title":"The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology","volume":"18","year":"1997","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20170720082429_dex220C18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1210\/endo-53-6-604","article-title":"Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin","volume":"53","year":"1953","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20170720082429_dex220C19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/ENDO:11:3:205","article-title":"Role of glycosylation in function of follicle-stimulating hormone","volume":"11","year":"1999","journal-title":"Endocrine"},{"key":"key\n\t\t\t\t20170720082429_dex220C20","author":"WHO","year":"2003"},{"key":"key\n\t\t\t\t20170720082429_dex220C21","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1210\/jc.2007-1342","article-title":"Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/32\/8\/1639\/18774911\/dex220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:16:19Z","timestamp":1750277779000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/dex220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,7]]},"references-count":21,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,6,7]]},"published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dex220","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,7]]}}}